IL1B and carcinoma: Our study found that, compared to adenomatous polyps where IL1B expression levels were unchanged, a notable increase in expression was evident in the transition phase toward carcinoma (Figure 5), suggesting its potential utility as a non-invasive biomarker for CRC.